Thoughts on this? >> Drug Channels News Roundup, June 2024: Cordavis Humira Update, OptumRx’s New Biosim Biz, Generic Drugs' Wild Ride, IRA Predictions, and Dr. G on Med School >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #pharmaceutical #biotech #healthcare #productmarketing
LucidQuest’s Post
More Relevant Posts
-
Thoughts on this? >> Biotech Stock Roundup: CRL for REGN, GILD's Drug Approval, LQDA Down on News - Zacks Investment Research >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharmaceutical #biotech #healthcare #pharma #competitivemarketing
Google News
To view or add a comment, sign in
-
Thoughts on this? >> Genespire raises €46.6 million (~$52 million) in a Series B - GlobeNewswire >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #competitivemarketing #pharmaceutical #healthcare #biotech #pharma
Google News
To view or add a comment, sign in
-
BioPharma & HealthTech Competitive Strategy & Insights | Digital & AI Solutions | Gene & Cell Therapy | Vaccines
Thoughts on this? >> Sarepta’s stock gains after Pfizer’s Duchenne trial failure - The Business Journals >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #healthcare #pharmaceutical #biotech #pharma #competitivemarketing
Google News
To view or add a comment, sign in
-
BioPharma & HealthTech Competitive Strategy & Insights | Digital & AI Solutions | Gene & Cell Therapy | Vaccines
Thoughts on this? >> Friday Five – Deals for days, Vyloy voyages to approval, Pfizer expands RSV reach…and more - FirstWord Pharma >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #competitivemarketing #biotech #pharmaceutical #healthcare
Google News
To view or add a comment, sign in
-
BioPharma & HealthTech Competitive Strategy & Insights | Digital & AI Solutions | Gene & Cell Therapy | Vaccines
Thoughts on this? >> bluebird bio Initiates Restructuring Intended to Optimize Cost Structure and Enable Quarterly Cash Flow Break-Even in the Second Half of 2025 - BioSpace >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #competitivemarketing #pharma #biotech #pharmaceutical #healthcare
Google News
To view or add a comment, sign in
-
BioPharma & HealthTech Competitive Strategy & Insights | Digital & AI Solutions | Gene & Cell Therapy | Vaccines
Thoughts on this? >> Biotech Stock Roundup: CRL for REGN, GILD's Drug Approval, LQDA Down on News - Zacks Investment Research >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharmaceutical #healthcare #pharma #biotech #competitivemarketing
Google News
To view or add a comment, sign in
-
BioPharma & HealthTech Competitive Strategy & Insights | Digital & AI Solutions | Gene & Cell Therapy | Vaccines
Thoughts on this? >> Ocuphire Pharma Announces Acquisition of Opus Genetics - GlobeNewswire >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #pharmaceutical #biotech #healthcare #competitivemarketing
Google News
To view or add a comment, sign in
-
Thoughts on this? >> Global Biopharma Thought Leaders Gather in London: Join the 2024 GenScript Biotech Global Forum for Cutting-Edge Insights - Longview News-Journal >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #competitivemarketing #pharmaceutical #healthcare #biotech #pharma
Google News
To view or add a comment, sign in
-
Thoughts on this? >> Trailblazers, iconoclasts and breakthrough artists are coming to the Endpoints biotech summit — please join us >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #productmarketing #pharma #pharmaceutical #biotech #healthcare
Trailblazers, iconoclasts and breakthrough artists are coming to the Endpoints biotech summit — please join us
To view or add a comment, sign in
-
BioPharma & HealthTech Competitive Strategy & Insights | Digital & AI Solutions | Gene & Cell Therapy | Vaccines
Thoughts on this? >> Roche doubles down on Dyno's AI-powered AAV tech, deal value swells to nearly $3B - FirstWord Pharma >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharmaceutical #biotech #healthcare #pharma #competitivemarketing
Google News
To view or add a comment, sign in
6,371 followers